Jose A. Malavet
Papers
1
Total Citations
2
H-Index
1
About
Dr. Jose A. Malavet is a thoracic surgeon whose research focuses on optimizing surgical outcomes for lung cancer patients, particularly through the lens of preoperative risk stratification. His work critically evaluates emerging prognostic biomarkers, most notably the blood urea nitrogen to serum albumin ratio (BAR), to determine their utility in predicting complications following robotic-assisted pulmonary lobectomy. In his 2023 study, Dr. Malavet and his team challenged the prevailing assumption that a high BAR reliably forecasts worse postoperative outcomes, providing evidence that this parameter may not be a robust predictor in this specific surgical context. This contribution is significant for refining clinical decision-making and avoiding unnecessary risk assessments based on unvalidated markers. While his most-cited paper has garnered 2 citations, its impact lies in its role as a cautionary note in the growing literature on prognostic indices, encouraging more rigorous validation before clinical adoption. Dr. Malavet’s work exemplifies the careful, evidence-based approach needed to advance precision in thoracic oncology surgery.
Research Focus
Key Achievements
Top Papers
- 1